AEMD Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares Modestly MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns GPCR Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected ASMB Q1 2026 Earnings Narrower Loss Surprises Market Shares Jump 694 LMRI Q1 2026 Earnings Strong EPS Beat Masks Revenue Concerns and Stock Decline HZO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Marine Retail Environment PLRX Q1 2026 Earnings Narrowerthanexpected Loss Highlights Clinical Pipeline Progress OXLCL Q4 2025 Earnings EPS Falls Short Amid Mixed Market Signals MYFW Q1 2026 Earnings Strong Earnings Beat with 4279 Surprise CPRI Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher STZ Q1 2026 Earnings EPS Surprises to the Upside Stock Slips